Vor Biopharma Inc. (CIK: 0001817229) EDGAR, Information, Filings... CompaniesBIO.Com

Vor Biopharma Inc.

Mailing address
100 CAMBRIDGEPARK DRIVE, SUITE 101, CAMBRIDGE, Delaware, 02140
Phone
617-655-6580
State location
Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

Vor Biopharma Inc. (CIK: 0001817229) is an American company incorporated in the state of Massachusetts. Head office is located at 100 CAMBRIDGEPARK DRIVE, SUITE 101, CAMBRIDGE, Massachusetts, 02140. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). Vor Biopharma Inc. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Attar Eyal C.	0001789076	Oct-11-2022	officer: Chief Medical Officer
RA Capital Healthcare Fund LP	0001315082	Feb-04-2021	director, 10 percent owner
RA CAPITAL MANAGEMENT, L.P.	0001346824	Feb-04-2021	director, 10 percent owner
Kolchinsky Peter	0001384859	Feb-04-2021	director, 10 percent owner
Patterson Matthew R	0001401018	Feb-04-2021	director
Beckman Daniella	0001513422	Feb-04-2021	director
Lubner David Charles	0001572000	Feb-04-2021	director
Schwab Andrew J.	0001598549	Feb-04-2021	10 percent owner
Shah Rajeev M.	0001619841	Feb-04-2021	director, 10 percent owner
PARMAR KUSH	0001664281	Feb-04-2021	director, 10 percent owner
Lundberg Sven Ante	0001682126	Feb-04-2021	director
Resnick Joshua	0001690959	Feb-04-2021	director
Alexandria Venture Investments, LLC	0001722024	Feb-04-2021	10 percent owner
PureTech Health LLC	0001727395	Feb-04-2021	10 percent owner
ANG ROBERT	0001741283	Feb-04-2021	director, officer: President and CEO
5AM Opportunities I, L.P.	0001753000	Feb-04-2021	10 percent owner
5AM Ventures VI, L.P.	0001753037	Feb-04-2021	10 percent owner
5AM Opportunities I (GP), LLC	0001790778	Feb-04-2021	10 percent owner
5AM Partners VI, LLC	0001829051	Feb-04-2021	10 percent owner
Chakraborty Tirtha	0001840685	Feb-04-2021	officer: Chief Scientific Officer
Kassim Sadik	0001840726	Feb-04-2021	officer: Chief Technology Officer
Slapak Christopher	0001841150	Feb-04-2021	officer: Chief Medical Officer
Jorgensen Nathan D.	0001842523	Feb-04-2021	officer: Chief Financial Officer

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Vor Biopharma Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001415889-25-023821 ( Act) Size: 0 KB	Sep-05-2025
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001959173-25-005742 (33 Act) Size: 0 KB	Sep-03-2025	001-39979 251288720
8-K	Document	Current report filing Acc-no: 0001193125-25-193600 (34 Act) Size: KB	Sep-02-2025	001-39979 251283543
SCHEDULE 13D/A	Document	Acc-no: 0001415889-25-023320 (34 Act) Size: KB	Aug-29-2025	005-92269 251282376
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001415889-25-023318 ( Act) Size: 0 KB	Aug-29-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001415889-25-023165 ( Act) Size: 0 KB	Aug-27-2025
8-K	Document	Current report filing Acc-no: 0001193125-25-189435 (34 Act) Size: KB	Aug-27-2025	001-39979 251262506
8-K	Document	Current report filing Acc-no: 0001193125-25-189169 (34 Act) Size: KB	Aug-27-2025	001-39979 251259846
424B5	Document	Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001193125-25-189133 (33 Act) Size: KB	Aug-27-2025	333-285969 251259752
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-25-107276 (34 Act) Size: KB	Aug-12-2025	001-39979 251206509
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-25-005593 (33 Act) Size: 0 KB	Aug-11-2025	001-39979 251201951
DEF 14A	Document	Definitive proxy statements Acc-no: 0001140361-25-029749 (34 Act) Size: KB	Aug-08-2025	001-39979 251196372
SCHEDULE 13G/A	Document	Acc-no: 0000315066-25-002153 (34 Act) Size: KB	Aug-06-2025	005-92269 251188539
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-25-005423 (33 Act) Size: 0 KB	Aug-04-2025	001-39979 251181992
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001415889-25-020551 ( Act) Size: 0 KB	Jul-30-2025
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001415889-25-020550 ( Act) Size: 0 KB	Jul-30-2025
PRE 14A	Document	Preliminary proxy statement not related to a contested matter or merger/acquisition Acc-no: 0001140361-25-027774 (34 Act) Size: KB	Jul-29-2025	001-39979 251161716
8-K	Document	Current report filing Acc-no: 0001193125-25-162644 (34 Act) Size: KB	Jul-22-2025	001-39979 251140890
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001415889-25-020024 ( Act) Size: 0 KB	Jul-18-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001415889-25-020022 ( Act) Size: 0 KB	Jul-18-2025

Recent 20 filings. View all Vor Biopharma Inc. filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Vor Biopharma Inc. overview
Vor Biopharma Inc. job
Vor Biopharma Inc. stock
Vor Biopharma Inc. ownership
Vor Biopharma Inc. CEO
Vor Biopharma Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.